PDF(Pubmed)
Abstract：
Metastatic thyroid cancer is rare. Here, the case of a patient with colon cancer that metastasized to the thyroid is described. The patient underwent radical rectal cancer surgery in August 2017 and received six cycles of chemotherapy with oxaliplatin and capecitabine postoperatively. On August 4, 2018, the patient was admitted to the hospital due to the discovery of thyroid nodules on ultrasound and carcinoembryonic antigen levels within the normal range. The biopsy from the fine needle aspiration suggested a malignant tumor. The patient underwent radical thyroid cancer surgery. Using intraoperative rapid frozen pathology, medullary carcinoma was diagnosed. Using postoperative routine pathology combined with immunohistochemistry results, thyroid metastasis from colorectal adenocarcinoma was diagnosed. After surgery, the patient regularly visited the outpatient clinic for chemotherapy with capecitabine. As of May 2023, the patient is still alive with no recurrence.
摘要：
转移性甲状腺癌是罕见的。这里,描述了转移到甲状腺的结肠癌患者的情况。患者于2017年8月接受直肠癌根治术，术后接受6周期奥沙利铂联合卡培他滨化疗。2018年8月4日，患者因超声发现甲状腺结节和癌胚抗原水平在正常范围内入院。细针穿刺活检提示恶性肿瘤。患者接受了甲状腺癌根治术。使用术中快速冷冻病理，诊断为髓样癌。采用术后常规病理结合免疫组化结果,诊断为结直肠腺癌的甲状腺转移。手术后,患者定期到门诊接受卡培他滨化疗。截至2023年5月，患者仍然活着，没有复发。
